YMAB
Y-mAbs Therapeutics, Inc
Price:  
8.61 
USD
Volume:  
760,675.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

YMAB Stock Forecast & Price Target

YMAB Stock Price Forecast

The average stock forecast for Y-mAbs Therapeutics, Inc (YMAB) in the next 12 months is 8.20 USD. This price target corresponds to an upside of -4.42%. The range of stock forecasts for YMAB is 3.03 - 9.03 USD. Based on the ratings of 16 analysts, the consensus recommendation for YMAB is HOLD.
Target Low Average Median High
Price (USD) 3.03 8.20 8.77 9.03
Upside -64.69% -4.42% 2.24% 5.24%

Recommendation Trends

The latest consensus rating for YMAB is "HOLD". This is the average recommendation of 16 analysts: 2 strong sell, 1 sell, 13 hold, 0 buy, 0 strong buy. In the previous period, 16 analysts also majorly recommmended "HOLD" for YMAB.

YMAB Financial Stock Forecast

Revenue This Year
84.85M
-3.23%
from 87.68M
Revenue Next Year
96.27M
13.45%
from 84.85M
EPS This Year
-0.84
28.26%
from -0.65
EPS Next Year
-0.95
14.02%
from -0.84